AZN Astrazeneca Plc

TIDMAZN

RNS Number : 4006A

AstraZeneca PLC

28 September 2015

Transactions by Person Discharging Managerial Responsibilities

Disclosure Rule DTR 3.1.4

On 25 September 2015, Dr Sean Bohen, EVP, Global Medicines Development & Chief Medical Officer, a person discharging managerial responsibilities, was granted awards under the terms of the AstraZeneca Performance Share Plan (AZPSP) and the AstraZeneca Restricted Share Plan (AZRSP) over the Company's American Depositary Shares (ADSs). Two ADSs equal one Ordinary Share of US$0.25 each.

 
                 ADSs awarded   ADSs awarded   Award price 
   Name           under AZPSP    under AZRSP       per ADS 
--------------  -------------  -------------  ------------ 
 
   Sean Bohen          16,003         51,802        $32.32 
--------------  -------------  -------------  ------------ 
 

The AZPSP award is subject to a combination of performance measures focused on AstraZeneca's scientific, commercial and financial performance assessed over a three-year performance period (1 January 2015 to 31 December 2017). The award will vest on the third anniversary of the date on which it was granted.

The AZRSP award will vest, subject to Dr Bohen's continued employment with the Company, as follows:

25,901 ADSs will vest on 25 September 2016

25,901 ADSs will vest on 25 September 2017

A C N Kemp

Company Secretary

28 September 2015

This information is provided by RNS

The company news service from the London Stock Exchange

END

RDSUWOARVOAKUAR

(END) Dow Jones Newswires

September 28, 2015 09:30 ET (13:30 GMT)

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Aug 2024 to Sep 2024

Astrazeneca (LSE:AZN)
Historical Stock Chart
From Sep 2023 to Sep 2024